Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

STAAR SURGICAL COMPANY

(STAA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Staar Surgical: Q3 Earnings Snapshot

11/03/2021 | 03:33pm EST

LAKE FOREST, Calif. (AP) _ Staar Surgical Co. (STAA) on Wednesday reported profit of $6 million in its third quarter.

On a per-share basis, the Lake Forest, California-based company said it had profit of 12 cents. Earnings, adjusted for stock option expense and non-recurring costs, came to 21 cents per share.

The maker of implantable lenses posted revenue of $58.4 million in the period, which topped Street forecasts. Three analysts surveyed by Zacks expected $57.7 million.

Staar Surgical expects full-year revenue in the range of $230 million to $231 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on STAA at https://www.zacks.com/ap/STAA

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about STAAR SURGICAL COMPANY
01/10STAAR SURGICAL : Announces Preliminary Fourth Quarter and Full Year 2021 Results - Form 8-..
PU
01/10STAAR Surgical Estimates $59 Million in Fiscal Q4 Sales
MT
01/10STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2021 Results
BU
01/10STAAR Surgical Company Provides Earnings Guidance for the Fourth Quarter and Full Year ..
CI
2021INSIDER SELL : Staar Surgical
MT
2021Brian Moore STAAR Surgical Company - VP of Investor, Media Relations & Corporate Develo..
PU
2021STAAR SURGICAL CO : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
2021STAAR SURGICAL : Q3 Earnings Snapshot
AQ
2021STAAR SURGICAL CO MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
2021STAAR Surgical Reports Third Quarter Net Sales of $58.4 Million Up 24% Y/Y - Form 8-K
PU
More news
Analyst Recommendations on STAAR SURGICAL COMPANY
More recommendations
Financials (USD)
Sales 2021 231 M - -
Net income 2021 24,6 M - -
Net Debt 2021 - - -
P/E ratio 2021 132x
Yield 2021 -
Capitalization 3 112 M 3 112 M -
Capi. / Sales 2021 13,5x
Capi. / Sales 2022 10,5x
Nbr of Employees 575
Free-Float -
Chart STAAR SURGICAL COMPANY
Duration : Period :
STAAR Surgical Company Technical Analysis Chart | STAA | US8523123052 | MarketScreener
Technical analysis trends STAAR SURGICAL COMPANY
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 65,39 $
Average target price 128,40 $
Spread / Average Target 96,4%
EPS Revisions
Managers and Directors
Caren L. Mason Director
Patrick F. Williams Chief Financial Officer & Vice President
Louis E. Silverman Chairman
Keith Holliday Chief Technology Officer
Scott D. Barnes Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
STAAR SURGICAL COMPANY-25.85%3 112
ABBOTT LABORATORIES-14.42%206 551
MEDTRONIC PLC-0.26%138 731
BECTON, DICKINSON AND COMPANY0.96%71 600
HOYA CORPORATION-18.59%44 518
BAXTER INTERNATIONAL INC.-1.41%42 374